about
VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancerVRK2 anchors KSR1-MEK1 to endoplasmic reticulum forming a macromolecular complex that compartmentalizes MAPK signalingEpidermal growth factor treatment enhances the kinase activity of kinase suppressor of RasThe product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase Cjkk-1 and mek-1 regulate body movement coordination and response to heavy metals through jnk-1 in Caenorhabditis elegansLack of evidence for KRAS oncogenic mutations in triple-negative breast cancer.Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.A microRNA signature associated with early recurrence in breast cancer.Conventional Matrices Loaded Onto a Graphene Layer Enhances MALDI-TOF/TOF Signal: Its Application to Improve Detection of Phosphorylated Peptides.Exploring the interactions of the RAS family in the human protein network and their potential implications in RAS-directed therapies.Chlorpheniramine inhibits the synthesis of ornithine decarboxylase and the proliferation of human breast cancer cell lines.Editorial: Mitogen Activated Protein Kinases.Expression of different mitogen-regulated protein/proliferin mRNAs in Ehrlich carcinoma cells.Cell autonomous apoptosis defects in acid sphingomyelinase knockout fibroblasts.The functional interaction of 14-3-3 proteins with the ERK1/2 scaffold KSR1 occurs in an isoform-specific manner.Niemann–Pick Disease versus acid sphingomyelinase deficiencyBAD Enables Ceramide to Signal Apoptosis via Ras and Raf-1Identification of Heterogeneous Ribonucleoprotein A1 as a Novel Substrate for Protein Kinase C ζ
P50
Q24294283-CFE4B0C3-C352-4205-BC0C-E6D28256E0B4Q24339458-088B1643-9B74-4EAD-8B77-AE336D4E268FQ28141723-BF8D462C-A781-4DDE-9358-6FCA27FB2E7FQ28289132-9EF14A1C-01EA-47D4-A02D-DDCD01D74258Q28359738-98359FCE-3304-4433-8192-683C07EBE45DQ33552870-A2B62177-05EE-42AD-A4B7-EB9E1C90AE11Q33721249-496CBE6B-38E0-4A27-AACF-4771EFD03562Q35121814-D6287A56-5630-424B-ABB3-9C3355B8075BQ35856231-D9D6F105-3364-4AFE-ADAB-EB1BADFB82A3Q38814045-6C6782DA-5120-45F2-BB4F-2AA0FCEB3197Q41316670-CBE38841-8075-43C8-AB2B-541167023C6BQ42360607-C26FBF54-32CF-4CE5-A329-19F7A5EC09F6Q42599103-1F0B3748-2B46-434E-81C6-8485CF79B612Q43508241-33A6D629-419A-4B98-9A17-6613D662AC76Q48756029-F3676D14-6319-449A-AE6C-4BB4047E6081Q59123099-3B42718C-8A42-47AC-9A3E-C41DDD8D2CD8Q59123101-2C93AF77-1E9E-4E33-AF8B-500E8BA52CA6Q59123103-BC7F7BBF-6898-42DA-8D1F-117471A1639B
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
José Lozano
@ast
José Lozano
@en
José Lozano
@es
José Lozano
@nl
type
label
José Lozano
@ast
José Lozano
@en
José Lozano
@es
José Lozano
@nl
altLabel
J Lozano
@en
prefLabel
José Lozano
@ast
José Lozano
@en
José Lozano
@es
José Lozano
@nl
P1053
C-2760-2014
P106
P21
P2798
P31
P3829
P496
0000-0002-8187-2833